Caspofungin (INN; brand name Cancidas) is a lipopeptide antifungal drug from Merck & Co., Inc. It is a member of a class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall.
via Wikipedia infobox
{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = | image = Caspofungin.svg | image_class = skin-invert-image | width = 275 | alt = | pronounce = | tradename = Cancidas | Drugs.com = | MedlinePlus = a615001 | DailyMedID = Caspofungin | pregnancy_AU = B3 | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = Intravenous | class = | ATC_prefix = J02 | ATC_suffix = AX04 | ATC_supplemental = | legal_AU = S4 | legal_AU_comment = | legal_BR = | legal_BR_comment = | legal_CA = | legal_CA_comment = | legal_DE = | legal_DE_comment = | legal_NZ = | legal_NZ_comment = | legal_UK = | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_EU = Rx-only | legal_EU_comment = | legal_UN = | legal_UN_comment = | legal_status = Rx-only
| bioavailability = 100% (intravenous use only) | protein_bound = ~97% | metabolism = Peptide hydrolysis, N-acetylation | metabolites = | onset = | elimination_half-life = 9–11 hours | duration_of_action = | excretion = Kidney (41%), feces (35%)
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).